Literature DB >> 30124653

Expression and Purification of Mammalian Bestrophin Ion Channels.

Alec Kittredge1, Nancy Ward1, Austin Hopiavuori1, Yu Zhang2, Tingting Yang3.   

Abstract

The human genome encodes four bestrophin paralogs, namely BEST1, BEST2, BEST3, and BEST4. BEST1, encoded by the BEST1 gene, is a Ca2+-activated Cl- channel (CaCC) predominantly expressed in retinal pigment epithelium (RPE). The physiological and pathological significance of BEST1 is highlighted by the fact that over 200 distinct mutations in the BEST1 gene have been genetically linked to a spectrum of at least five retinal degenerative disorders, such as Best vitelliform macular dystrophy (Best disease). Therefore, understanding the biophysics of bestrophin channels at the single-molecule level holds tremendous significance. However, obtaining purified mammalian ion channels is often a challenging task. Here, we report a protocol for the expression of mammalian bestrophin proteins with the BacMam baculovirus gene transfer system and their purification by affinity and size-exclusion chromatography. The purified proteins have the potential to be utilized in subsequent functional and structural analyses, such as electrophysiological recording in lipid bilayers and crystallography. Importantly, this pipeline can be adapted to study the functions and structures of other ion channels.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30124653      PMCID: PMC6126599          DOI: 10.3791/57832

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  26 in total

1.  Bestrophin, the product of the Best vitelliform macular dystrophy gene (VMD2), localizes to the basolateral plasma membrane of the retinal pigment epithelium.

Authors:  A D Marmorstein; L Y Marmorstein; M Rayborn; X Wang; J G Hollyfield; K Petrukhin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

Review 2.  Bestrophin 1 and retinal disease.

Authors:  Adiv A Johnson; Karina E Guziewicz; C Justin Lee; Ravi C Kalathur; Jose S Pulido; Lihua Y Marmorstein; Alan D Marmorstein
Journal:  Prog Retin Eye Res       Date:  2017-01-30       Impact factor: 21.198

Review 3.  Drug discovery and development for rare genetic disorders.

Authors:  Wei Sun; Wei Zheng; Anton Simeonov
Journal:  Am J Med Genet A       Date:  2017-07-21       Impact factor: 2.802

Review 4.  Combining cryo-electron microscopy (cryo-EM) and cross-linking mass spectrometry (CX-MS) for structural elucidation of large protein assemblies.

Authors:  Carla Schmidt; Henning Urlaub
Journal:  Curr Opin Struct Biol       Date:  2017-11-05       Impact factor: 6.809

5.  Mutations in the VMD2 gene are associated with juvenile-onset vitelliform macular dystrophy (Best disease) and adult vitelliform macular dystrophy but not age-related macular degeneration.

Authors:  F Krämer; K White; D Pauleikhoff; A Gehrig; L Passmore; A Rivera; G Rudolph; U Kellner; M Andrassi; B Lorenz; K Rohrschneider; A Blankenagel; B Jurklies; H Schilling; F Schütt; F G Holz; B H Weber
Journal:  Eur J Hum Genet       Date:  2000-04       Impact factor: 4.246

6.  Rem, a member of the RGK GTPases, inhibits recombinant CaV1.2 channels using multiple mechanisms that require distinct conformations of the GTPase.

Authors:  Tingting Yang; Xianghua Xu; Timothy Kernan; Vincent Wu; Henry M Colecraft
Journal:  J Physiol       Date:  2010-03-22       Impact factor: 5.182

7.  Preassociated apocalmodulin mediates Ca2+-dependent sensitization of activation and inactivation of TMEM16A/16B Ca2+-gated Cl- channels.

Authors:  Tingting Yang; Wayne A Hendrickson; Henry M Colecraft
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-08       Impact factor: 11.205

8.  Mutations in a novel gene, VMD2, encoding a protein of unknown properties cause juvenile-onset vitelliform macular dystrophy (Best's disease).

Authors:  A Marquardt; H Stöhr; L A Passmore; F Krämer; A Rivera; B H Weber
Journal:  Hum Mol Genet       Date:  1998-09       Impact factor: 6.150

9.  Biallelic mutation of BEST1 causes a distinct retinopathy in humans.

Authors:  Rosemary Burgess; Ian D Millar; Bart P Leroy; Jill E Urquhart; Ian M Fearon; Elfrida De Baere; Peter D Brown; Anthony G Robson; Genevieve A Wright; Philippe Kestelyn; Graham E Holder; Andrew R Webster; Forbes D C Manson; Graeme C M Black
Journal:  Am J Hum Genet       Date:  2008-01       Impact factor: 11.025

10.  Missense mutations in a retinal pigment epithelium protein, bestrophin-1, cause retinitis pigmentosa.

Authors:  Alice E Davidson; Ian D Millar; Jill E Urquhart; Rosemary Burgess-Mullan; Yusrah Shweikh; Neil Parry; James O'Sullivan; Geoffrey J Maher; Martin McKibbin; Susan M Downes; Andrew J Lotery; Samuel G Jacobson; Peter D Brown; Graeme C M Black; Forbes D C Manson
Journal:  Am J Hum Genet       Date:  2009-10-22       Impact factor: 11.025

View more
  4 in total

1.  Dual Ca2+-dependent gates in human Bestrophin1 underlie disease-causing mechanisms of gain-of-function mutations.

Authors:  Changyi Ji; Alec Kittredge; Austin Hopiavuori; Nancy Ward; Shoudeng Chen; Yohta Fukuda; Yu Zhang; Tingting Yang
Journal:  Commun Biol       Date:  2019-06-24

Review 2.  Structure and Function of the Bestrophin family of calcium-activated chloride channels.

Authors:  Aaron P Owji; Alec Kittredge; Yu Zhang; Tingting Yang
Journal:  Channels (Austin)       Date:  2021-12       Impact factor: 2.581

3.  Structures and gating mechanisms of human bestrophin anion channels.

Authors:  Aaron P Owji; Jiali Wang; Alec Kittredge; Zada Clark; Yu Zhang; Wayne A Hendrickson; Tingting Yang
Journal:  Nat Commun       Date:  2022-07-04       Impact factor: 17.694

4.  ATP activates bestrophin ion channels through direct interaction.

Authors:  Yu Zhang; Alec Kittredge; Nancy Ward; Changyi Ji; Shoudeng Chen; Tingting Yang
Journal:  Nat Commun       Date:  2018-08-07       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.